Revenio Group Corporation, Stock Exchange Release February 23, 2016 at 13.30
                     
NOTICE OF THE ANNUAL GENERAL MEETING

Notice is given to the shareholders of Revenio Group Corporation of the annual general meeting to be held on March 15, 2016, at 5 p.m. at Finlandia Hall, Veranda 2 hall, Mannerheimintie 13 e, FI-00100 Helsinki, Finland (entrances M4 and K4). The reception of persons who have registered for the meeting and the distribution of voting tickets will commence at 3.30 p.m.

Before the meeting at 4 p.m., Olli-Pekka Salovaara, CEO of Revenio Group Corporation, Timo Hildén, CEO of Icare Finland Oy, Ari Kukkonen, R&D Director of Revenio Research Oy and Ville-Pekka Seppä, R&D Manager of Revenio Research Oy will give a presentation on Revenio Group Corporation's R&D projects. After the annual general meeting is held, the shareholders will have the opportunity to meet the managing directors of the Revenio Group Corporation at a coffee event.

A. Matters on the agenda of the general meeting

The following matters will be considered at the General Meeting:

1. Opening of the meeting

2. Calling the meeting to order

3. Election of the persons to confirm the minutes and to supervise the counting of votes

4. Recording the legal convening of the meeting and quorum

5. Recording the attendance at the meeting and adoption of the list of votes

6. Presentation of the annual accounts, the Report of the Board of Directors, and the auditor's report for the year 2015

- Review by the President and CEO.

7. Adoption of the annual accounts

8. Resolution on the use of the profit shown on the balance sheet and the payment of dividend

The Board of Directors proposes to the AGM that a per-share dividend of EUR 0.70 be paid for the financial year 2015. The dividend is paid to those shareholders who, on the dividend record date of March 17, 2016, are entered as shareholders on the Company's shareholder register as held by Euroclear Finland Ltd. The Board proposes that the dividend payment date be March 24, 2016.

9. Resolution on the discharge of the members of the Board of Directors and the President and CEO from liability

10. Resolution on the remuneration of the members of the Board of Directors and on the grounds for compensation of travel expenses

11. Resolution on the number of members of the Board of Directors

12. Election of the members of the Board of Directors

13. Resolution on the remuneration of the auditor

The Board of Directors proposes that remuneration for the auditor shall be paid against the auditor's reasonable invoice.

14. Election of the auditor

The Board of Directors proposes PricewaterhouseCoopers Oy to be re-elected as the auditor.     

15. Authorizing the Board of Directors to decide to repurchase the Company's own shares

The Board of Directors proposes that the AGM authorize the Board to decide to repurchase a maximum of 795,392 of the Company's own shares in one or several tranches using the Company's non-restricted equity capital.  

The company may buy back shares in order to develop its capital structure, finance and implement any corporate acquisitions or other transactions, implement share-based incentive plans, or otherwise transfer or cancel them.

The company may buy back shares in public trading on marketplaces whose rules and regulations allow the Company to trade in its own shares. In such a case, the Company buys back shares through a directed purchase, that is, in a proportion other than its shareholders' holdings in Company shares, with the consideration for the shares based on their publicly quoted market price, in such a manner that the minimum price of the purchased shares equals the lowest market price quoted in public trading during the authorization period, and, similarly, their highest price equals the highest market price quoted in public trading during that period.

The Board proposes that the authorization be valid until April 30, 2017. This authorization shall supersede the buyback authorization granted at the AGM of March 19, 2015. 

16. Authorization to the Board of Directors to decide on a share issue and on the granting of stock options and other special rights giving entitlement to shares

The Board of Directors proposes that the AGM authorize the Board to decide on a share issue of a maximum of 795,392 shares or to grant special rights (including stock options) entitling holders to shares as referred to in Chapter 10 Section 1 of the Companies Act, in one or several tranches.

This authorization is proposed to be used to finance and implement any prospective corporate acquisitions or other transactions, to implement the company's share-based incentive plans, or for other purposes determined by the Board.  

The authorization is also proposed to grant the Board the right to decide on all terms and conditions governing said share issue and the granting of special rights, including the subscribers or the grantees of said special rights and the payable consideration. The authorization also includes the right to waive shareholders' pre-emptive subscription rights and covers the issue of new shares and the transfer of any shares that may be held by the company.

The Board proposes that the authorization be valid until April 30, 2017. This authorization shall supersede the authorization to decide on a share issue and on the granting of special rights giving entitlement to shares granted in the AGM of March 19, 2015.

17. Closing of the meeting

B. Documents of the General Meeting

The abovementioned proposals for resolution on the AGM agenda and this notice are available on the website of Revenio Group Corporation at www.revenio.fi. Revenio Group Corporation's Annual Report, including the financial statements, Report of the Board of Directors and auditor's report, will be available on the website no later than February 23, 2016. Proposals for resolution and the abovementioned documents will also be available at the AGM, and copies of them as well as this notice will be sent to shareholders upon request. The Minutes of the AGM will be available on the abovementioned website from March 29, 2016 onwards.

C. Instructions to meeting participants

1. Shareholders registered in the shareholder register

Shareholders who are registered in the Company's shareholder register maintained by Euroclear Finland Ltd on March 3, 2016, have the right to attend the AGM. Shareholders whose shares are registered in their personal book-entry accounts in Finland are registered in the shareholder register of the Company.

Shareholders who are registered in the Company's shareholder register and wish to participate in the AGM must register for the meeting no later than March 10, 2016 at 4:00 p.m., by which time registration notices need to have been received. Registration options for the General Meeting are:

a) through the Company's website at www.revenio.fi
b) via e-mail to elina.kari@revenio.fi or
c) by mail to Revenio Group Corporation, General Meeting, Äyritie 22, FI-01510 Vantaa, Finland.

Upon registration, shareholders should give their name, personal identity code, address, telephone number, name of assistant or proxy representative, if any, and the personal identity code of the proxy representative. Personal information given by shareholders to Revenio Group Corporation shall be used only in connection with the General Meeting and with the processing of related registrations. Shareholders, their representatives or proxy representatives must be able to prove their identity and/or proxy authorization at the meeting venue. 

2. Holders of nominee-registered shares

A holder of nominee-registered shares has the right to participate in the AGM by virtue of such shares based on which the holder would, on March 3, 2016, be entitled to be registered in the shareholder register held by Euroclear Finland Ltd. Moreover, in order to participate in the AGM, holders of nominee-registered shares are required to be temporarily registered, based on such shares, in the shareholder register held by Euroclear Finland Ltd, no later than March 10, 2016, at 10:00 a.m. For nominee-registered shares, this constitutes due registration for the General Meeting.

Holders of nominee-registered shares are advised to request, without delay, all necessary instructions pertaining to registration in the temporary shareholder register, the issuing of proxy documents, and registration for the General Meeting from their asset managers. The asset manager's account operator must sign up holders of nominee-registered shares who wish to participate in the General Meeting for registration to the Company's temporary shareholder register no later than on the aforementioned date and time.

3. Proxy representation and powers of attorney

Shareholders may participate in the General Meeting and exercise their rights at the meeting by way of proxy representation. A shareholder's proxy representative shall present a dated power of attorney or shall otherwise in a reliable manner prove that he/she is authorized to represent the shareholder. If a shareholder participates in the General Meeting by way of several proxy representatives, representing the shareholder with shares in different securities accounts, the shares by which each proxy representative represents the shareholder must be identified upon registration.

Proxy documents, if any, should be delivered as originals to Revenio Group Corporation, General Meeting, Äyritie 22, FI-01510 Vantaa, Finland, before the last date for registration.

4. Other instructions and information

Pursuant to Chapter 5, Section 25 of the Finnish Companies Act, a shareholder who is present at the General Meeting has the right to request information on matters on the meeting's agenda.

On the date of this notice, February 23, 2016, the total number of shares in Revenio Group Corporation is 7,953,928, representing the same number of votes.

Vantaa, February 23, 2016

Revenio Group Corporation
Board of Directors

For further information, please contact:
President & CEO Olli-Pekka Salovaara, tel. +358 40 567 5520
olli-pekka.salovaara@revenio.fi
www.revenio.fi

DISTRIBUTION:
NASDAQ OMX Helsinki
Financial Supervisory Authority (FIN-FSA)
Principal media
www.revenio.fi

The Revenio Group in brief

Revenio is a Finnish, globally operating health technology corporation whose worldwide success is based on a strongly patented intraocular pressure measurement technology. The Revenio Group consists of Icare Finland Oy, Revenio Research Oy and Oscare Medical Oy, in which Revenio holds a 53% interest. The common denominators of Revenio's business operations include screening, follow-up and the global need to make cost savings through preventive health care. Revenio seeks vigorous growth in health technology. Revenio aims at developing even more efficient and easily adopted methods for the early-stage detection of diseases with significance for public health. The focus of Revenio's screening technology is on the early detection of glaucoma, osteoporosis, skin cancer and asthma, and the monitoring of these during the treatment process.

In 2015, the Revenio Group's net sales totaled MEUR 20.3, with its operating margin for continuing operations standing at 28.4%. Revenio Group Corporation is listed on Nasdaq Helsinki.